01:04 PM EST - BetterLife Pharma Inc : Announced that its wholly-owned subsidiary, Altum Pharmaceuticals Inc., has signed an agreement with an European-based investor group to complete a non-brokered financing of up to US$5.0 million by way of private placement of Altum’s common shares. The financing will be in tranches and will commence January of 2022. At the completion of the US$5.0 million financing, the investor group will own approximately 12.5% of Altum’s issued and outstanding shares. BetterLife Pharma Inc
shares C.BETR are trading up $0.03 at $0.23.
